Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Yongsheng ^a   Zhang, Yunpeng ^b   Li, Shengli ^a   Lu, Jianping ^a   Chen, Juan ^a   Wang, Yuan ^a   Li, Yixue ^a   Xu, Juan ^a   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

UNTRANSLATED RNA;

BREAST TUMOR; CASE CONTROL STUDY; CLUSTER ANALYSIS; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETICS; HUMAN; OPEN READING FRAME; PROCEDURES; PROMOTER REGION; TRANSCRIPTION INITIATION SITE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OPEN READING FRAMES; PROMOTER REGIONS, GENETIC; RNA, UNTRANSLATED; TRANSCRIPTION INITIATION SITE;

EID: 84924231097     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08790     Document Type: Article

References (58)

1. Hon, G. C. et al. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome research 22, 246-258, doi:10.1101/gr.125872.111 (2012
2. Hervouet, E., Cartron, P. F., Jouvenot, M. & Delage-Mourroux, R. Epigenetic regulation of estrogen signaling in breast cancer. Epigenetics 8, 237-245, doi:10.4161/epi.23790 (2013
3. Hill, V. K. et al.Genome-wideDNAmethylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer research 71, 2988-2999, doi:10.1158/0008-5472.CAN-10-4026 (2011
4. Fackler, M. J. et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer research 71, 6195-6207, doi:10.1158/0008-5472.CAN-11-1630 (2011
5. Cui, P. et al. A comparison between ribo-minus RNA-sequencing and polyAselected RNA-sequencing. Genomics 96, 259-265, doi:10.1016/j.ygeno.2010.07.010 (2010
6. Pandey, R. R. et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 32, 232-246, doi:10.1016/j.molcel.2008.08.022 (2008
7. Flintoft, L. Non-coding RNA: Structure and function for lncRNAs. Nat Rev Genet 14, 598, doi:10.1038/nrg3561 (2013
8. Ponting, C. P., Oliver, P. L. & Reik, W. Evolution and functions of long noncoding RNAs. Cell 136, 629-641, doi:10.1016/j.cell.2009.02.006 (2009
9. Nie, Y. et al. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer science 104, 458-464, doi:10.1111/cas.12092 (2013
10. Augoff, K., McCue, B., Plow, E. F. & Sossey-Alaoui, K. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triplenegative breast cancer. Molecular cancer 11, 5, doi:10.1186/1476-4598-11-5 (2012
11. Mercer, T. R. & Mattick, J. S. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 20, 300-307, doi:10.1038/nsmb.2480 (2013
12. Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A. & Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic acids research 34, D140-144, doi:10.1093/nar/gkj112 (2006
13. Iorio, M. V. & Croce, C. M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4, 143-159, doi:10.1002/emmm.201100209 (2012
14. Wu,W.K. et al.MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29, 5761-5771, doi:10.1038/onc.2010.352 (2010
15. Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10, 704-714, doi:10.1038/nrg2634 (2009
16. Suzuki, H., Maruyama, R., Yamamoto, E. & Kai, M. DNA methylation and microRNA dysregulation in cancer. Mol Oncol 6, 567-578, doi:10.1016/j.molonc.2012.07.007 (2012
17. Baer, C., Claus, R. & Plass, C. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer research 73, 473-477, doi:10.1158/0008-5472.CAN-12-3731 (2013
18. Weber, B., Stresemann, C., Brueckner, B. & Lyko, F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6, 1001-1005 (2007
19. Shen, J. et al. Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma. Epigenetics 7, 1230-1237, doi:10.4161/epi.22140 (2012
20. Zhang, Z. et al. Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells. Genes Cancer 2, 782-791, doi:10.1177/1947601911429743 (2011
21. Li, D. et al. Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17, 1722-1730, doi:10.1158/1078-0432.CCR-10- 1800 (2011
22. Vrba, L., Munoz-Rodriguez, J. L., Stampfer, M. R. & Futscher, B.W. miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One 8, e54398, doi:10.1371/journal.pone.0054398 (2013
23. Gu, F. et al. CMS: a web-based system for visualization and analysis of genomewide methylation data of human cancers. PLoS ONE 8, e60980, doi:10.1371/journal.pone.0060980 (2013
24. Yan, L. X. et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14, 2348-2360, doi:10.1261/rna.1034808 (2008
25. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688, doi:10.1038/nature06174 (2007
26. Ponjavic, J., Oliver, P. L., Lunter, G. & Ponting, C. P. Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS genetics 5, e1000617, doi:10.1371/journal.pgen.1000617 (2009
27. Jia, H. et al.Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 16, 1478-1487, doi:10.1261/rna.1951310 (2010
28. Koga, Y. et al. Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome research 19, 1462-1470, doi:10.1101/gr.091447.109 (2009
29. Bajic, V. B., Choudhary, V. & Hock, C. K. Content analysis of the core promoter region of human genes. In Silico Biol 4, 109-125 (2004
30. Brinkman, A. B. et al. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome research 22, 1128-1138, doi:10.1101/gr.133728.111 (2012
31. Liao, Q. et al. Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic acids research 39, 3864-3878, doi:10.1093/nar/gkq1348 (2011
32. Guo, X. et al. Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks. Nucleic acids research 41, e35, doi:10.1093/nar/gks967 (2013
33. Wamstad, J. A. et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 151, 206-220, doi:10.1016/j.cell.2012.07.035 (2012
34. Dolfi, S. C. et al. The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab 1, 20, doi:10.1186/2049-3002-1-20 (2013
35. Wang, C., Bian, Z., Wei, D. & Zhang, J. G.miR-29b regulates migration of human breast cancer cells. Molecular and cellular biochemistry 352, 197-207, doi:10.1007/s11010-011-0755-z (2011
36. Zhang, L., Sullivan, P. S., Goodman, J. C., Gunaratne, P. H. & Marchetti, D. MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer research 71, 645-654, doi:10.1158/0008-5472.CAN-10-1910 (2011
37. Rice, J. C., Ozcelik, H.,Maxeiner, P., Andrulis, I. & Futscher, B.W.Methylation of the BRCA1 promoter is associated with decreased BRCA1mRNA levels in clinical breast cancer specimens. Carcinogenesis 21, 1761-1765 (2000
38. Cao, W. et al. Integrated analysis of long noncoding RNA and coding RNA expression in esophageal squamous cell carcinoma. International journal of genomics 2013, 480534, doi:10.1155/2013/480534 (2013
39. Cheng, C., Ung,M., Grant, G. D. & Whitfield, M. L. Transcription factor binding profiles reveal cyclic expression of human protein-coding genes and non-coding RNAs. PLoS computational biology 9, e1003132, doi:10.1371/journal.pcbi.1003132 (2013
40. Lucas, J. J., Domenico, J. & Gelfand, E. W. Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells. Molecular cancer research:MCR 2, 105-114 (2004
41. Pic-Taylor, A., Darieva, Z., Morgan, B. A. & Sharrocks, A. D. Regulation of cell cycle-specific gene expression through cyclin-dependent kinase-mediated phosphorylation of the forkhead transcription factor Fkh2p. Molecular and cellular biology 24, 10036-10046, doi:10.1128/MCB.24.22.10036-10046.2004 (2004
42. Dhillon, A. S., Hagan, S., Rath, O. & Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290, doi:10.1038/sj.onc.1210421 (2007
43. Hynes, N. E. Tyrosine kinase signalling in breast cancer. Breast cancer research: BCR 2, 154-157 (2000
44. Fernandez-Medarde, A. & Santos, E. Ras in cancer and developmental diseases. Genes Cancer 2, 344-358, doi:10.1177/1947601911411084 (2011
45. Sanchez-Munoz, A. et al. Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer. BMC cancer 10, 136, doi:10.1186/1471-2407-10-136 (2010
46. Cho, W. C. OncomiRs: the discovery and progress of microRNAs in cancers. Molecular cancer 6, 60, doi:10.1186/1476-4598-6-60 (2007
47. Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nature genetics 41, 178-186, doi:10.1038/ng.298 (2009
48. Kim, J. H. et al. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome research 21, 1028-1041, doi:10.1101/gr.119347.110 (2011
49. Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905, doi:10.1038/nature08822 (2010
50. Gibbs, J. R. et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS genetics 6, e1000952, doi:10.1371/journal.pgen.1000952 (2010
51. Jacobsen, A. et al. Analysis of microRNA-target interactions across diverse cancer types. Nat Struct Mol Biol 20, 1325-1332, doi:10.1038/nsmb.2678 (2013
52. Aure, M. R. et al. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome biology 14, R126, doi:10.1186/gb-2013-14-11-r126 (2013
53. Varley, K. E. et al. Recurrent read-through fusion transcripts in breast cancer. Breast cancer research and treatment 146, 287-297, doi:10.1007/s10549-014- 3019-2 (2014
54. Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43-49, doi:10.1038/nature09906 (2011
55. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome research 22, 1775-1789, doi:10.1101/gr.132159.111 (2012
56. Wu, S. C., Kallin, E. M. & Zhang, Y. Role of H3K27 methylation in the regulation of lncRNA expression. Cell research 20, 1109-1116, doi:10.1038/cr.2010.114 (2010
57. Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74, doi:10.1038/nature11247 (2012
58. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature biotechnology 28, 511-515, doi:10.1038/nbt.1621 (2010